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Cord blood lymphocytes (CBL) were compared with adult peripheral blood lymphocytes 
(a-PBL) for their: (i) natural killer (NK) and antibody-dependent cellular cytotoxic (ADCC) 
activities, (ii) target-binding capacity, (iii) ability to induce soluble natural killer cytotoxic factor 
(NKCF), (iv) interferon (IFN>, interleukin 2 (IL-2)-, and lectin-induced augmentation of NK 
activity, and (v) ability to produce IFN against tumor targets in vitro. CBL depleted of adherent 
cells and Percoll-separated, NK-enriched subpopulations demonstrated significantly lower NK, 
ADCC, and target-binding activities compared to a-PBL. CBL produced significantly lower 
levels of NKCF directed against K562 tumor targets in comparison with a-PBL. Although the 
NK activity of CBL was not stimulated by either IFN or IL2 to the same levels shown by 
a-PBL, the percentage enhancement of cytotoxicity of CBL by IFN and IL-2 was greater than 
that of a-PBL. Lectin-induced enhancement of cytotoxicity was significantly greater for CBL 
in comparison with a-PBL. Further, the ability of CBL lymphocytes to produce EN--r in vitro 
against K562 target cells was significantly lower than that of adult PBL. These studies suggest 
an association between decreased NK, ADCC, and target-binding activities, induction of NKCF 
and IFN production by CBL, and increased susceptibility of neonates to infection. o 1985 
Academic F’ress, Inc. 
INTRODUCTION 
Neonates are known to have increased susceptibility to disseminated and devas- 
tating infections (1, 2). Earlier studies showed that the immune system of the 
newborn is deficient in several aspects of humoral and cellular immunity (1, 3). 
Natural killer (NQ4 cells and cells mediating antibody-dependent cellular cytotoxic 
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(ADCC) activities are important because of their probable role in immune surveillance 
against cancer and viral infections and in the regulation of various lymphocyte 
reactions (4-7). Regulatory effects of NK cells on hematopoietic stem cell proliferation 
have been demonstrated (8). The ability of cord blood lymphocytes (CBL) to 
mediate NK and ADCC activities has been reported with conflicting findings (9- 
14). The present study examines the NK and ADCC activities of CBL in comparison 
with adult lymphocytes (a-PBL) and attempts to delineate the molecular and cellular 
basis of the NK defect by examining the target-binding ability and production of 
natural killer cytotoxic factor (NKCF) and interferon (IFN) in vitro. These studies 
are consistent with a relationship between the deficiency of NK, ADCC, and target- 
binding activities of cord blood lymphocytes and reduced NKCF and IFN production. 
MATERIALS AND METHODS 
Preparation of Efector Cells 
Neonatal umbilical cord blood samples were collected in heparinized tubes (20 
U/ml) under sterile conditions from healthy term infants at vaginal delivery before 
the expulsion of the placenta. Heparinized (20 U/ml) peripheral blood was obtained 
simultaneously from healthy unrelated adult volunteers of either sex (20 to 40 years 
of age). Blood samples were processed immediately after collection. Donors or their 
parents were apprised of the study and consents were obtained consistent with the 
policies of the University of Michigan and the NIH. Mononuclear cells from both 
adult and cord blood samples were isolated using a modified method of Boyum 
(15). Blood was diluted with an equal volume of Ca2’- and Mg2+-free Hanks’ 
balanced salt solution [HBSS (GIBCO, Grand Island, N.Y.)] and centrifuged at 
400g for 30 min at 18°C over a cushion of Ficoll-Hypaque (Pharmacia Fine 
Chemicals, Piscataway, N.J.). The mononuclear cell band was harvested, washed 
three times with HBSS, and resuspended in RPM1 1640 medium containing 25 
mM Hepes buffer supplemented with 10% heat-inactivated fetal calf serum [FCS 
(GIBCO)], 80 &ml gentamicin (Schering Corp., Kenilworth, N.J.), and 300 pg 
fresh glutamine/ml (complete medium). 
Depletion of Adherent Cells 
Mononuclear cells were depleted of adherent cells as described (6). Briefly, total 
mononuclear cells were suspended in RPM1 1640 with 10% FCS and passaged 
through a 7-ml column of Sephadex G-10 beads (Pharmacia) equilibrated in the 
same medium. After 45 min of incubation at 37°C nonadherent cells were washed 
through with 1 bed vol of warm (37°C) medium. The cell recovery was >70% of 
the total input, and monocyte contamination as indicated by nonspecific esterase 
staining was <2%. 
Percoll Fractionation of Lymphocytes 
The enrichment of NK and ADCC effector cells using a discontinuous gradient 
of Percoll (Pharmacia) was carried out as described elsewhere (6). To prepare a 
discontinuous density gradient, Percoll solution was mixed at various concentrations 
with RPM1 1640 medium and 2-ml aliquots (ranging from 50.0 to 37.5% in 2.5% 
increments) were gently layered into 15 X 130-mm round-bottom glass test tubes. 
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Adherent cell-depleted lymphocytes were layered on top of the gradient and 
centrifuged at 300g for 45 min at 20°C. Six fractions, with the uppermost (37.5%) 
designated “0” and the lowermost (50.0%) designated “V”, were collected from the 
top with a Pasteur pipet and washed twice in RPM1 1640 medium. Recovery of 
cells was -85% of the input, and viability always exceeded 95% by trypan blue dye 
exclusion. 
Preparation of Tumor Target Cells 
Mycopiasma-free human erythroleukemia cell line K-562 was used as target for 
NK cells. For the ADCC assay, we chose as target an antibody-coated human 
B-cell leukemia line (SB) because of its resistance to NK activity in a 4-hr “Cr 
release assay. Tumor target cells were serially passaged in complete medium and 
used in cytotoxicity assays no more than 48 hr after the last passage. To 0.8-ml 
aliquots of complete medium containing 5 X lo6 washed tumor cells, 200 PCi of 
51Cr as sodium chromate (New England Nuclear, Boston, Mass.) was added. The 
cells were incubated at 37°C for 1 hr in a humidified atmosphere of 5% CO* in air, 
with intermittent shaking. After incubation, the cells were washed three times with 
complete medium and resuspended to a concentration of 1 X lo5 cells/ml. 
Assay for NK Activity 
NK activity was measured in a direct “Cr release assay as previously described 
(6, 16, 17). A fixed number of viable effector cells in complete medium was added 
to triplicate cultures of “Cr-labeled targets in V-bottom microtitration plates 
(CoStar, Cambridge, Mass.). After centrifugation at 40g for 2 min, they were 
incubated at 37°C in a humidified atmosphere of 5% COz in air for 4 hr. At the 
end of incubation the plates were centrifuged at 400g for 10 min and 100-d aliquots 
were removed from each well and transferred to glass tubes and read in a Packard 
Model 593 gamma counter. Percentage cytotoxicity was calculated as follows: 
% cytotoxicity = 
experimental release - spontaneous release 
total release - spontaneous release 
x 100, 
where spontaneous release represents counts released from control wells containing 
only 1 X lo4 target cells, and total release represents counts obtained from an 
aliquot of 1 X lo4 target cells. Cytotoxicity was also expressed as lytic units (LU)/ 
10’ effector cells, defined as the number of effector cells needed to yield 30% 
cytotoxicity of 1 X IO4 target cells. LU were calculated from the cytotoxicity curve 
using four different E:T cell ratios for each test by linear regression analysis as 
described by Kadish et al. (18). 
Assay for ADCC 
The ADCC activity of effector cells was determined as previously described (6, 
16, 17). Briefly, 50 ~1 of varying concentrations of effector cells were added to 50 
~1 of complete medium containing 51Cr-labeled SB target cells and 100 ~1 of a 2 
X 10e4 dilution of rabbit anti-SB antisera previously found to yield maximum 
ADCC. Percentage cytotoxicity was calculated as described above for NK activity 
with the following exceptions. Spontaneous release represents counts released in 
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control wells containing effector cells, labeled SB target cells, and media instead of 
anti-SB antibodies, and total release represents counts obtained in an aliquot of 1 
X lo4 51Cr-labeled target cells. 
Lectin-Dependent Cell-Mediated Cytotoxicity (LDCC) Assay 
The LDCC assay was carried out in a manner similar to that of the NK assay 
except that NK-resistant SB cells were used as targets. Briefly, different numbers of 
target and effector cells were added to V-bottom microtitration plates and various 
concentrations of phytohemagglutininP [PHA, Difco, Detroit, Mich. (1, 2.5, and 5 
Fg/ml)] were added to a final volume of 0.2 ml and incubated for 4 hr at 37°C in 
a humidified 5% CO2 in air incubator. Percentage LDCC activity was calculated as 
described for NK activity and was compared with cytotoxicity observed with control 
cultures containing effector and target cells in the absence of PHA. Percentage 
cytotoxicity was calculated as 
% cytotoxicity = 
experimental Release - spontaneous Release 
total Release - spontaneous Release 
x 100, 
where spontaneous release represents counts released from control wells containing 
1 X lo4 target cells plus lectin and total release represents counts obtained in an 
aliquot of 1 X lo4 target cells. The cytotoxicity was expressed as lytic units (LU)/ 
lo7 effector cells as described for NK assay. 
Interferon (IFN) 
Recombinant IFN-(I! (specific activity, - 1 X 10’ U/mg protein) was a gift from 
the Schering Corporation, Bloomfield, New Jersey. IFN-(u was diluted in RPM1 
1640 and stored at -70°C before use. The maximum NK-augmenting dose was 
250 U/ml as previously determined. IFN-a was diluted in RPM1 1640 medium and 
stored at -70” before use. 
Interleukin 2 (IL-2) 
Commercially available IL-2 (Electra-Nucleonics Labs, Inc., Silver Spring, Md.) 
was diluted in RPM1 1640 and stored at -70°C before use. IL-2 was purified from 
human peripheral blood leukocytes by several chromatographic steps and was 
devoid of any lectin or IFN. A 10% final concentration, the maximum NK- 
augmenting dose as previously determined, was used. 
Treatment of E_ff^ector Cells with IFN or IL-2 
Effector cells (2 X 106/ml) were washed and suspended in 1 ml of RPM1 1640 
plus 5% FCS to which IFN-(I! or IL-2 was added. Cultures were incubated for 24 hr 
at 37°C in a humidified atmosphere of 5% COz in air, washed twice, and resuspended 
in medium. Control cultures were treated identically with the exception that either 
IFN-ar or IL-2 was not added. Viability of treated lymphocytes was unaffected as 
assessed by trypan blue dye exclusion. Both treated and control cultures were 
assayed for NK activity. 
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Target-Binding Assay 
A target-binding assay was used as described by Haliotis et al. (19). In brief, 
lymphocytes were washed twice and mixed with a fivefold excess of tumor cells, 
centrifuged at 15Og for 5 min, and incubated at 37°C for 5 min. Following 
incubation, lymphocyte-target mixtures were transferred to ice, the pellets were 
gently resuspended, and the number of lymphocytes binding to tumor targets was 
determined using a hemocytometer. 
Interferon Assay 
Lymphocytes were cultured alone or with K562 target cells at a ratio of 1OO:l 
for 18 hr at 37°C in 5% CO1 in air, after which they were centrifuged and the 
supemates were collected for IFN assay. Supemates were quantitated for IFN using 
a modified calorimetric assay of Borden and Leonhardt (20). Briefly, 96-well flat- 
bottom microtitration plates (Costar) were seeded with the human epithelial cell 
line WISH at a concentration of 3 X lo4 cells/well in 0.1 ml of media and incubated 
for 18 hr. Serial dilutions of supernates (1: 10, 1:40, 1: 160, and 1:320) were added 
in 0.1 ml and incubated again for I8 hr. The cells were then infected with vesicular 
stomatitis virus, 200 plaque forming units/well, for 24 hr. After development of 
cytopathic effect the cultures were washed with PBS and overlaid with 0.2 ml of 
0.015% neutral red in saline and incubated for 2 hr at 37°C. The monolayers were 
washed and the cell-bound dye was eluted with a 1:l solution of absolute ethanol: 
0.2 M NaHzP04. As a control, an IFN preparation standardized against NIH 
reference GO23-901-527 of known concentrations ranging from 2 to 300 U/ml was 
included in the assay. This assay is highly reproducible and can detect as little as 4 
U/ml of IFN. 
Generation of Soluble Natural Killer Cytotoxic Factor (NKCF) 
The preparation of NKCF was carried out as described by Farram and Targan 
(21). Briefly, effector cells were mixed with NK-sensitive unlabeled K562 target cells 
at a 1OO:l effector-to-target-cell ratio for 24 hr in sterile V-bottom microtitration 
plates (Dynatech Labs, Alexandria, Va.). They were then centrifuged at 15Og for 10 
min, and the supemates (NKCF) were collected and tested for cytotoxic activity 
against fresh target cells, As controls, either K562 or effector cells were incubated 
separately in media alone and supemates were collected as described above and 
used as mock NKCF. 
Assay for NKCF 
K562 target cells were labeled with 5’Cr as described above and suspended at a 
concentration of 1 X lo5 cells/ml to which NKCF or mock NKCF at a final 
concentration of 25% (v/v) was added and incubated for 24 hr at 37°C in 5% CO2 
in air. At the end of incubation, the plates were centrifuged and loo-p1 aliquots 
were removed from each well and counted as described for the NK assay. Percentage 
cytotoxicity was calculated as 
% cytotoxicity = 
experimental release (NKCF) - spontaneous release (Mock NKCF) x loo 
total release - spontaneous release (Mock NKCF) 
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RESULTS 
NK and ADCC Activities of Cord Blood Lymphocytes 
Lymphocytes depleted of adherent cells from 15 cord blood and 10 adult 
peripheral blood samples were tested for their NK and ADCC activity against tumor 
target cells. Data presented in Table 1 show that CBL depleted of adherent cells 
demonstrated significantly lower NK and ADCC activities, respectively, against 
K562 and antibody-coated SB target cells compared to normal adult lymphocytes 
at all E:T cell ratios. E:T cell ratios higher than 5O:l produced similar differences 
(data not shown). The possibility that dilution of NK cells with other cells of the 
neonatal lymphocyte pool may be responsible for the diminution of NK and ADCC 
activities was examined using Percoll-enriched NK and ADCC effector cells. The 
data presented in Fig. 1 reveal that NK- and ADCC-enriched CBL from fraction 
“0” also showed significantly diminished NK (25%, P < 0.025) and ADCC (21%, 
P < 0.01) activities compared to higher NK (68%) and ADCC (52%) activities 
displayed by a similar Percoll fraction of a-PBL. CBL from fraction II also 
manifested lower levels of NK (8%, P < 0.05) and ADCC activities (12%, P < 0.025) 
as contrasted with the levels of NK (26%) and ADCC (18%) activities manifested 
by the same fraction of a-PBL. Lymphocytes from nonlytic fractions II to V of both 
CBL and a-PBL did not manifest significant differences in NK or ADCC activities. 
Target-Binding Ability of CBL 
To examine whether the diminished cytotoxicity observed with CBL is due to 
failure to interact with a target recognition structure rather than inhibition of the 
lytic mechanism, target-binding assays were performed. The results presented in 
TABLE 1 




Effector:target cell ratio 
Cytotoxicity (%)b 







51.2 + 15.6 31.1 f  10.0 
(P < 0.025)s (P < 0.01) 
13.1 + 6.1 9.2 + 4.6 
39.5 * 9.5 29.4 * 8.2 
(P < 0.05) (P < 0.05) 
12.4 zk 9.6 10.5 + 6.3 
19.6 + 5.0 
(P < 0.025) 
6.2 f  3.3 
23.6 + 5.6 
(P < 0.025) 
1.7 + 3.2 
12.6 f  2.3 
(P < 0.005) 
3.6 + 2.1 
8.5 f  1.9 
(P < 0.025) 
2.6 k 1.7 
a Effector cells were mixed with targets at varying E:T cell ratios in a 4-hr 5’Cr release assay. The results 
are means + SD of 15 different cord blood lymphocyte samples and 10 unrelated adult peripheral blood 
lymphocyte samples. 
b Percentage cytotoxicity was calculated as under Materials and Methods. 
’ Erythroleukemia cell line used as targets in the NK assay. 
d B-Leukemia cell line sensitized with anti-SB antibody used as targets in the ADCC assay. 
’ Adult peripheral blood lymphocytes depleted of adherent cells. 
‘Cord blood lymphocytes depleted of adherent cells. 
8 Differences in values between CBL and a-PBL were statistically significant at all E:T ratios in both 
NK and ADCC assays using a single-tailed Student’s t test. 
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l NK-a-PBL 
I 1 0 NK-CBL 
FIG. 1. NK and ADCC activities of PercoB-enriched cord blood lymphocytes and adult peripheral 
blood lymphocytes. Values represent mean percentage cytotoxicity + SD of three separate experiments 
with triplicate determinations for each experiment at 20~1 E:T cell ratio. Statistical significance was 
determined using a single-tailed Student’s t test. 
Table 2 show that CBL demonstrated a lower percentage of conjugates formed with 
target cells (6.5%) compared to a-PBL (13.5, P < 0.05). This suggests that the NK 
deficiency of CBL may be associated with defects in binding events. 
Efect of Lectin on Cellular Cytotoxicity of CBL 
Since CBL demonstrated reduced NK and ADCC activities and target binding 
ability compared to a-PBL, we examined whether the cytotoxic activity of CBL 
could be stimulated with lectin. Data presented in Table 3 demonstrate that a-PBL 
produced significantly increased cytotoxicity, i.e., 19 (P < 0.05) 22 (P < 0.05) and 
18 (P < 0.025) LU against SB targets at 1, 2.5, and 5 pg/ml of PHA, respectively, 
compared to a negligible cytotoxicity (5 LU) displayed in the absence of PHA. CBL 
exhibited a cytotoxicity of 4 LU without PHA which was significantly enhanced to 
31 (P < 0.05), 31 (P < 0.05), and 49 (P < 0.05) LU by PHA at 1, 2.5, and 5 pg/ 
TABLE 2 
Target Binding Ability of Cord Blood Lymphocytes” 
Effector cells Target-binding lymphocytes @o)~ 
a-PBL’ 
CBL* 
13.5 * 3.1 
(P < 0.05)’ 
6.5 + 2.4 
a Effector and target cells were mixed at an ET ratio of 5: 1 and incubated at 37°C for 30 min, followed 
by 0°C for 1 hr. Aliquots were examined in a hemocytometer and % positive target-binding cells was 
scored for each lymphocyte binding two or more target cells. Results are expressed as means + SD of 15 
CBL and 7 a-PBL samples performed in duplicate. 
b The human erythroleukemia cell line, K562, was used as target in the binding study. 
’ Adult peripheral blood lymphocytes depleted of adherent cells. 
*Cord blood lymphocytes depleted of adherent cells. 
e Statistical significance was determined using a single-tailed Student’s t test. 
166 NAIR, SCHWARTZ, AND MENON 
ml concentrations, respectively. These data demonstrate that the percentage en- 
hancement of cytotoxicity by PHA was greater for CBL than for a-PBL. 
Ability of CBL to Produce Soluble NKCF 
We further investigated whether a decreased ability of CBL to synthesize and 
release NKCF might be responsible for their diminished cytotoxicity when compared 
to a-PBL. Data presented in Table 4 show that culture supernates (NKCF) of CBL 
plus target cells manifested decreased cytotoxicity ( 14%) against fresh K562 target 
cells as compared to a higher cytotoxicity (24%) displayed by NKCF produced by 
a-PBL (P < 0.05). This suggests that diminished production and secretion of NKCF 
may, in part, explain the decreased cytotoxicity of CBL. 
Efect of IFN-a and IL-2 on the NK Activity of CBL 
IFN-(I! and IL-2, agents known to augment the NK activity of lymphocytes, were 
examined for their potential to enhance the decreased cytotoxicity of CBL (Table 
5). We observed that a-PBL precultured with IFN-a for 24 hr produced higher 
cytotoxicity (137 LU) compared to a lower cytotoxicity (86 LU) displayed by 
untreated lymphocytes (P < 0.05). Preculture of a-PBL with IL-2 also demonstrated 
a significantly higher cytotoxicity of 173 LU compared to 86 LU shown by untreated 
a-PBL (P < 0.0 1). CBL precultured with IFN and IL-2 also showed an enhancement 
of their cytotoxicity, 122 LU (P < 0.05) and 183 LU (P < O.OOS), respectively, 
compared to 58 LU produced by untreated CBL. These data indicate that although 
the cytotoxicity of CBL could not be enhanced to absolute values comparable to 
a-PBL levels, the percentage enhancement of cytotoxicity of CBL by IFN-a (110.6%) 
and IL-2 (215%) was remarkably higher than a-PBL augmented by IFN (59%) and 
IL-2 ( 110%). 
TABLE 3 




source (&ml): 0 1 2.5 5 
a-PBL’ 5.4 + 2.9 19.8 +- 5.7 [266]’ 22.8 f  6.4 [322] 18.7 + 4.6 [246] 
(P < 0.05)J (P < 0.025) (P < 0.025) 
CBLd 4.6 + 3.2 31.2 + 11.7 [578] 31.3 + 11.0 [580] 49.7 + 18.5 [980] 
(P < 0.05) (P < 0.05) (P < 0.05) 
p The LDCC assay was carried out in a manner similar to that of the NK assay except the NK-resistant 
SB cell line was used as targets as described under Materials and Methods. 
* Cytotoxicity is expressed as LU/ 10’ effector cells as described under Materials and Methods. Values 
are mean LU + SD of four separate experiments performed in triplicate. 
c Adult peripheral blood lymphocytes depleted of adherent cells. 
d Cord blood lymphocytes depleted of adherent cells. 
’ Values in brackets are % enhancement of LDCC caIcu1ated in comparison to control. 
‘Statistical values were determined by a single-tailed Student’s t test. 
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TABLE 4 
Effect of Soluble Natural Killer Cytotoxic Factor from Cord and Adult Peripheral 
Blood Lymphocytes on K562 Targets” 
Source of NKCF Cytotoxicity ’ (%) 
a-PBL + K562’ 
CBL + K562* 
24.2 f  4.1 
(P < 0.05)’ 
13.8 + 1.9 
n Adult PBL or CBL were precultured separately with NK-sensitive unlabeled K562 target cells at an 
E:T cell ratio of lOO:l, for 24 br at 37°C in 5% CO2 in air. The supemates were collected and used as 
putative NKCF against fresh 5’Cr-lab&d K562 target cells at a final concentration of 25% (v/v) as 
described under Materials and Methods. Results are the means of 10 different CBL-NKCF and 7 different 
a-PBL-NKCF samples + SD performed in triplicate. 
* Calculated as under Materials and Methods. 
c Adult peripheral blood lymphocytes depleted of adherent cells + unlabeled K562 target cells. 
*Cord blood lymphocytes depleted of adherent cells + unlabeled K562 target cells. 
e Differences in values between PBL and CBL were statistically significant using a single-tailed Student’s 
I test. 
Interferon-y Production by CBL in Vitro 
Susceptibility of target cells to NK lysis may be partially dependent upon the 
ability of effector lymphocytes to produce IFN against the target cells (22). As CBL 
demonstrated diminished NK activity, target binding, and NKCF production 
compared to a-PBL, we examined whether the ability of CBL to produce IFN-?/ in 
vitro against K562 tumor targets could also be correlated with their reduced cytotoxic 
response. Data presented in Table 6 demonstrate that all CBL samples produced 
TABLE 5 
Effect of IFN and IL-2 on NK Activity of Lymphocytes” 
Effector cells Treatment Cytotoxicity (LU)b 
Percentage 
enhancement’ 
a-PBL* None 86.2 k 12.2 - 
a-PBL IFN 137.2 f  22.4 (P < 0.05)’ 59.1 
a-PBL IL-2 173.0 f  23.9 (P -=c 0.01) 100.6 
CBL’ None 58.2 + 8.2 - 
CBL IFN 122.6 + 21.6 (P c: 0.05) 110.6 
CBL IL-2 183.5 f  32.3 (P < 0.005) 215.2 
’ Effector cells were cultured alone or with IFN (250 U/ml) or IL-2 (10% v/v) for 24 hr at 37°C 
washed, and tested for NK activity against prelabeled K562b target cells. 
b NK reactivity was calculated as LU/lO’ effector cells as under Materials and Methods. Values 
represent mean LU k SD of five separate experiments done in triplicate. 
‘Percentage enhancement was calculated in comparison to the NK reactivity of untreated control 
lymphocytes. 
* Adult peripheral blood lymphocytes depleted of adherent cells. 
’ Cord blood lymphocytes depleted of adherent cells. 
‘Statistical significance was determined using a single-tailed Student’s t test. 
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remarkably lower levels of IFN-7, with a range of 4 to 1680 U/ml (except for one 
sample, No. 5, which produced 3685 U/ml), in response to K562 target cells as 
compared to a higher level of IFN-7 produced by a-PBL. Thus, reduced IFN-7 
production by CBL may also be associated, in part, with their decreased ability to 
mediate NK activity. 
DISCUSSION 
Since newborns are more susceptible to various infections than are adults (1, 2), 
analysis of their immune status is an important clinical parameter. Although 
deficiencies of both humoral and cell-mediated immunity have been observed in 
neonates, the underlying cellular and molecular mechanisms remain unclear. In 
humans, reports on the ontogeny of NK cells are conflicting (23-25). Defects in the 
ability of neonatal lymphocytes to mediate NK and ADCC activities against tumor- 
and virus-infected targets have been described by several investigators (9, 11). Frazier 
et al. (26) showed that NK and ADCC activities of CBL against Herpes simplex 
virus (HSV)-infected Chang liver cells were lower than those of a-PBL. They further 
demonstrated that the NK and ADCC activities of lymphocytes from babies 
delivered by C-section without labor were significantly lower than the NK and 
ADCC activities of lymphocytes from neonates delivered vaginally. The proportion 
of certain lymphocyte subpopulations like OKTl l+ (27), OKT8+ (28), HNKl+ (12, 
25) or Fc receptor+ (29) was also reported to be lower in newborns than adults. 
Numerous studies have shown the presence of active suppressor cells or their soluble 
mediators in CBL (27, 30). The present investigation (Table 1) shows that CBL 
from babies delivered vaginally demonstrate reduced NK and ADCC activities 
against tumor target cells compared to a-PBL. 
NK and ADCC effector cells have been described as large granular lymphocytes 
(LGL) containing azurophilic granules with a high cytoplasmic:nuclear ratio and a 
sedimentation profile at lower densities in a Percoll gradient (3 1). Tarkkanen and 
Saksela ( 14) showed an equivalent percentage of LGL in neonates and adult 
mononuclear populations. Although the percentage yield of LGL in Percoll fractions 
0 and I are similar in both CBL and a-PBL populations (data not presented), the 
CBL subpopulation enriched on Percoll gradient fractions 0 and I demonstrated 
significantly lower NK and ADCC activities compared to an equal number of 
a-PBL similarly enriched (Fig. 1). CBL from fractions II to V (nonlytic fractions) 
showed negligible NK and ADCC activities, which suggested that CBL effector cells 
do not have sedimentation characteristics different from those observed with a-PBL. 
Further, we examined whether the diminished cytotoxicity of CBL may be due to 
a decreased target-binding ability of effector cells. It was observed that CBL exhibited 
a decreased target-binding capacity compared to a-PBL (Table 2), indicating that 
the reduced cytotoxicity of CBL may be partly due to a defective target-binding 
capacity in addition to a possible diminution of the intrinsic lytic mechanism of 
effector cells. This is consistent with the finding of Kohl et al. (32), who showed 
that total mononuclear cord blood cells manifest decreased early target cell recognition 
or binding against Chang liver target cells. 
Several investigators have observed that NK cells function through the release of 
soluble mediator(s), namely natural killer cytotoxic factor. Exogenous NKCF has 
been demonstrated to be cytotoxic to sensitive target cells (21, 33). In the present 
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report, we examined whether a decreased ability of CBL to synthesize and secrete 
NKCF is responsible for their reduced NK activity. Our results show that NKCF 
from CBL displayed significantly lower cytotoxicity compared to NKCF from 
a-PBL, suggesting that such a deficiency in NKCF production by CBL may be 
responsible, in part, for their decreased NK activity (Table 4). 
IFN and IL-2 play a major role in immunoregulation (6, 34-38) and the 
augmentation of NK activity both in vitro and in vivo (6, 34, 35). IFN appears to 
enhance NK activity by several mechanisms, including stimulation of noncytotoxic 
pre-NK cells to mature cytotoxic effector cells (24) or activation of mature NK cells 
that are transiently inactive (36, 37). Alternatively, IFN may potentiate endogenous 
lytic mechanisms by stimulating the development of new receptors or modulating 
preexisting effector cell surface molecules or their avidity (24, 36, 38). It has also 
been shown that IL-2 can induce IFN; this has been used successfully in the 
establishment of NK clones (39). Recently Svedersky et al. (40) reported that 
augmentation of NK activity by IL-2 and IFN involves overlapping mechanisms. 
The present investigation describes a higher relative response of CBL to IFN and 
IL-2 compared to a-PBL, although the cytotoxicity of the former was not enhanced 
to the same absolute levels shown by a-PBL. It is possible that a specific subpopulation 
of lymphocytes such as precursor effector or pre-NK cells, which may be more 
sensitive to IFN-(u and IL2 signals, may be more abundant in cord blood than in 
adult peripheral blood. Further, active cytotoxic effecters may be relatively decreased 
in cord blood compared to adult blood. Several investigators have demonstrated 
that spontaneous suppressor cell activity is greater in cord blood than in adult blood 
TABLE 6 
Interferon Activity of Culture Supemates from Effector and Target Cells” 
Source of culture supemate 
Interferon activity 
W/ml1 b 
K562 + CBL-I 1680 
K562 + CBL-2 700 
K562 + CBL-3 230 
K562 + CBL-4 <4 
K562 + CBL5 3685 
K562 + CBL-6 420 
K562 + CBL-7 40 
K562 + CBL-8 160 
K562 + CBL-9 240 
K562 + CBLlO 60 
K562 + a-PBL 2800 
K562 + a-PBL 2677 
K562 + a-PBL 2163 
K562 + a-PBL 2334 
K562 + a-PBL 2465 
(1 Mixtures of effector and unlabeled K562 target cells were set up at 1oO:l ET cell ratio at 37°C for 
24 hr in 5% CO2 in air. Supemates were obtained from cell cultures and assayed for IFN as described 
under Materials and Methods. 
b Results are expressed as means + SD of triplicate determinations of 10 individual CBL and 5 different 
a-PBL samples. 
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(3, 4 1 ), and cord blood cells are able to produce soluble suppressor factors which 
are capable of inhibiting various functions of adult lymphocytes (30). Enhancement 
of NK activity by IFN may also be due to the inhibition of suppressor cells or their 
soluble products. This is supported by our earlier investigation in which the 
suppressive effect of soluble suppressor factors produced by normal lymphocyte 
cultures on NK activity could be completely reversed by IFN (6). Bryson et al. (42) 
showed that human CBL can produce IFN-(u and IFN-~ but not IPN-y when 
stimulated with PHA. IPN has been shown to enhance the cytotoxicity of lymphocytes 
against tumor and virus-infected target cells. The magnitude of and sensitivity to 
IFN production in vivo may determine, in part, the neonate’s ability to resist 
infection. The present investigation demonstrates that CBL produce considerably 
less IFN-y in vitro in response to tumor target cells in comparison with a-PBL. 
Although our functional assay does not discriminate the type of IPN present, 
treatment of culture supernates containing IFN at acidic pH (pH 2-3) eliminated 
the IFN activity, demonstrating that IFN-y was produced by CBL in response to 
tumor target cells (Table 6). This deficiency of IFN-y production may be due to a 
dysfunction of accessory cells (43) or to the effect of suppressor cells or their 
mediators (30, 44). 
Since the fetus represents an allograft in the maternal environment, a decrease in 
the cytotoxic response of the feto-maternal unit may inhibit graft-vs-host reactions 
as well as facilitate the expansion and development of hematopoietic stem cells 
which are known to be regulated by NK cells (8). In view of the significant ability 
of IFN or IL2 to enhance the NK activity of neonatal lymphocytes as reported 
herein, these important biological modifier agents may have therapeutic potential 
in the treatment of severe neonatal viral infections. 
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